Global Next Generation Sequencing Market was valued at US$ 5,731.3 Mn in 2017 and is estimated to reach US$ 26,501.2 Mn by 2025
According to a new market research study titled 'Next Generation Sequencing Market to 2025 - Global Analysis and Forecasts by Product, Services, Applications, and End-Users, the global next generation sequencing market was valued at US$ 5,731.3 Mn in 2017 and is estimated to reach US$ 26,501.2 Mn by 2025. The report highlights the trends prevalent in the global next generation sequencing market and the factors driving the market along with those that act as deterrents to its growth.

The global next generation sequencing market is a matured market in the developing countries as well as developing economies worldwide. The necessity of genetic analysis is constantly increasing in recent days due to the reliable and accurate results being offered by the technique. The demand for next generation sequencing is experienced mostly from academic institutions followed by hospitals & clinics. Among the applications, the demand for next generation sequencing is significantly high in diagnostics, drug discovery, followed by precision medicine. Furthermore, advancements in sequencing technologies and declining cost of sequencing is expected to be a driving factor for the next generation market.

Modification and automation of this process continued to increase sequencing data and time reduction. Thereby allowing researchers to reach major milestones in the Human Genome Project. NGS makes sequence based gene expression analysis a "digital? alternative to analog techniques. It also aids in quantifying RNA expression with the breadth of a microarray and the resolution of qPCR. Advancement in genome sequencing has made the sequencing easy and accurate. These technological advancement are likely to grow the market in near future.

Cancer can be cured if diagnosed and treated at an initial stage. Cancer sequencing using next-generation sequencing (NGS) methods provides more information. Additionally, NGS also aids in diagnostics and treatment of cancer. In recent years, the cases of cancer has been increasing tremendously and the trend is anticipated to remain the same in the upcoming years. Due to preference of better technologies for detection of fatal disease, the demand for next generation sequencing is anticipated to witness constant growth in the upcoming years.

The market for next generation sequencing is well established in the region of North America, owing to the awareness regarding medical practices and technological developments in the process of next generation technology. Various market players have been focusing towards shifting their customer base in North America. For instance, Illumina, Inc. along with Telegraph, established a company called Verogen. The company would be entitled to provide Illumina's forensic products to the customers in the US.


The key players operating in the field of Next Generation Sequencing worldwide include PerkinElmer, Inc., Oxford Nanopore Technologies, Ltd., Beijing Genomics Institute, Macrogen, Inc., F. Hoffmann-La Roche AG, Agilent Technologies, Eurofins Scientific, Qiagen N.V., Thermo Fisher Scientific, and Illumina, Inc. among others

The report segments the global next generation sequencing market as follows:

Global Next Generation Sequencing Market - By Product

Platforms

Hiseq Series
Miseq Series
Solid
ION Torrent
Pacbio Rs II & Sequel Systems
Other Platforms

Services

Sequencing Services
RNA sequencing services
Whole Genome Sequencing Services
Whole Exome Sequencing Services
Targeted Sequencing Services
Chip Sequencing Services
Other Sequencing Services

Data Management & Analysis Services Market

NGS Data Analysis Market
NGS Data Analysis Software & Workbenches
Other Data Management & Analysis Services

Consumables

Sample Preparation Consumables

DNA fragmentation, End Repair, A-Tailing, and Size Selection Kits & Reagents
Library Preparation & Target Enrichment Kits & Reagents
Quality Control Kits & Reagents

Other NGS Consumables

Global Next Generation Sequencing Market - By Technology

Genome Sequencing
Exome Sequencing
Resequencing & Targeted Sequencing Oil & Gas
DNA-based Resequencing & Targeted Sequencing
RNA-based Resequencing & Targeted Sequencing
Other Sequencing Technologies

Global Next Generation Sequencing Market - By Application
Diagnostics
Drug Discovery
Precision Medicine
Others

Global Next Generation Sequencing Market - By End-User
Academic & Research Institutes
Pharmaceutical & Biotechnology Companies
Hospitals & Clinics
Other End Users

Global Next Generation Sequencing Market - By Geography

North America
U.S.
Canada
Mexico

Europe
UK
Germany
France

Asia Pacific (APAC)
Japan
China
India

Middle East & Africa (MEA)
South Africa
UAE

South America (SAM)
Brazil